Skip to main content

UBS Group AG

Position in OCS — Oculis Holding AG

CIK 1610520 ZURICH, V8

Position in OCS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,530,095
+$861,680 QoQ
Shares Held
182,715
+190.0% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 59 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in OCS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. OCS ranks #196 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 OCSAW 300
2026-06-30 $2,530,095 182,415
2026-03-31 OCSAW 270
2026-03-31 $1,668,415 62,746
2025-12-31 OCSAW 170
2025-12-31 $916,941 45,916
2025-09-30 OCSAW 170
2025-09-30 $1,313,787 74,732
2025-06-30 OCSAW 170
2025-06-30 $2,455,655 126,515
2025-03-31 OCSAW 490
2025-03-31 $2,149,722 112,965
2024-12-31 $1,850,314 108,842
2024-09-30 $217,944 17,777
2024-06-30 OCSAW 9,652
2024-06-30 $197,174 16,500
2024-03-31 $13,218 1,097
2023-09-30 $22,022 2,002
2023-06-30 $24 2
2023-03-31 $9,005 1,212